This study exists to understand whether the medication MP-214 is both safe enough and useful enough to take further. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
Multiple locations, including Sapporo
SchizophreniaDrugA study involving a medication or substance.From 20 Years to 64 Years
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
This study is completed in the Netherlands. It is testing Safety and efficacy of repeated low dose D-lysergic acid diethylamide (LSD) D-Tartrate as treatment for ADHD.
This study exists to understand whether the medication RGH-188 is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
Multiple locations, including Encino
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
This study is completed in Austria, in Hungary, in Germany, .... It focuses on Schizophrenia.
In Austria
SchizophreniaOther
Countries
Austria, Hungary, Germany, ...
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only) 3. SERVIER Research and Development ICTR (For United Kingdom only)
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.